Results 311 to 320 of about 128,389 (322)

AMN107 (nilotinib): a novel and selective inhibitor of BCR-ABL

British Journal of Cancer, 2006
Heide Spiegel
exaly  

PF-114, a potent and selective inhibitor of native and mutated BCR/ABL is active against Philadelphia chromosome-positive (Ph+) leukemias harboring the T315I mutation

Leukemia, 2014
A. Mian, Anahita Rafiei, I. Haberbosch, Alexey A. Zeifman, I. Titov, V. S. Stroylov, Anna Metodieva, O. Stroganov, F. Novikov, Boris Brill, G. Chilov, Dieter Hoelzer, O. Ottmann, M. Ruthardt   +13 more
semanticscholar   +1 more source

Allosteric inhibitors of Bcr-abl–dependent cell proliferation

Nature Chemical Biology, 2006
Paul W Manley
exaly  

Leukemie s fusním genem BCR/ABL.

2013
Philadelphia (Ph) chromosome, as a result of reciprocal translocation, is in majority of cases connected to two types of leukaemia - chronic myelogenous (CML) and acute lymphoblastic (ALL). The translocation occurs within large intronic sequences of BCR and ABL genes.
openaire   +2 more sources

Mechanisms of BCR–ABL in the pathogenesis of chronic myelogenous leukaemia

Nature Reviews. Cancer, 2005
R. Ren
semanticscholar   +1 more source

BCR-ABL uncouples canonical JAK2-STAT5 signaling in chronic myeloid leukemia

Nature Chemical Biology, 2012
Oliver Hantschel, Florian Grebien, Kay-uwe Wagner   +2 more
exaly  

Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia

Nature Medicine, 2017
Meenu Kesarwani, Kakajan Komurov, Jose A Cancelas   +2 more
exaly  

BCR/ABL Oncogene

2013
M. Madden Felicella, K.-Y. Jen
openaire   +1 more source

BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review

Leukemia Research, 2010
Amit K Tiwari, Amit K Tiwari, Zhe-sheng Chen   +2 more
exaly  

Clinical Significance of BCR-ABL Fusion Gene Subtypes in Chronic Myelogenous and Acute Lymphoblastic Leukemias

Asian Pacific Journal of Cancer Prevention, 2014
exaly